Status:
COMPLETED
Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strategy.
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Eye Trauma
Eligibility:
All Genders
Brief Summary
Vicryl (polyglactin) 10-0 resorbable suture is rarely used, little known to ophthalmologists but may offer therapeutic and practical advantages in eligible cases of corneal trauma, particularly during...
Eligibility Criteria
Inclusion
- Corneal penetrating injury and/or lamellar laceration
Exclusion
- Corneal Penetrating injury trauma requiring necessarily ONLY Nylon 10-0
- Traumatism requiring necessarily a cryopreserved human amniotic membrane (for example)
- Traumatism eligible for biological glue (long-axis wound \< 2 mm)
Key Trial Info
Start Date :
March 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 5 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04733846
Start Date
March 18 2020
End Date
December 5 2021
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint-Etienne
Saint-Etienne, France